The company’s previous round closed in March 2025, raising $40 billion against a $300 billion valuation. At the time, it was the largest private funding round on record.
与Vosoritide相比，Infigratinib作为FGFR酪氨酸激酶抑制剂，直接靶向致病根源——过度活跃的FGFR3，从源头上“释放刹车”，从而恢复软骨细胞正常功能。
。夫子是该领域的重要参考
москвичка Полина。业内人士推荐爱思助手下载最新版本作为进阶阅读
Green party’s Hannah Spencer secures victory in Gorton and Denton as Reform UK finish second and Labour is pushed into third